Результаты поиска

Cardiovascular Disease After Hematopoietic Stem Cell Transplantation in Adults: JACC: CardioOncology State-of-the-Art Review.

The use of hematopoietic cell transplantation (HCT) has expanded in the last 4 decades to include an older and more comorbid population. These patients face an increased risk of cardiovascular disease after HCT. The risk varies depending on several factors, including the type of transplant (autologous or allogeneic). Many therapies used in HCT have the potential to be cardiotoxic. Cardiovascular complications after HCT include atrial arrhythmias, heart failure, myocardial infarction, and pericardial effusions. Before HCT, patients should undergo a comprehensive cardiovascular assessment, with

Совпадение в полном тексте источника
… Acute coronary syndrome associated with alemtuzumab infusion in multiple sclerosis. Neurology. 2018;90:852–854. doi: 10.1212/WNL.0000000000005417. 34. Basquiera A.L., Berretta A.R., García J.J., Palazzo E.D. Coronary ischemia related to alemtuzumab therapy. … Acute cardiotoxicity associated with alemtuzumab infusion for multiple sclerosis. Mult Scler. 2020;26:735–737. doi: 10.1177/1352458519855725. 37. Armenian S.H., Sun C.L., Shannon T., et al. Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation. …

Cytokines in CAR T Cell-Associated Neurotoxicity.

Chimeric antigen receptor (CAR) T cells provide new therapeutic options for patients with relapsed/refractory hematologic malignancies. However, neurotoxicity is a frequent, and potentially fatal, complication. The spectrum of manifestations ranges from delirium and language dysfunction to seizures, coma, and fatal cerebral edema. This novel syndrome has been designated immune effector cell-associated neurotoxicity syndrome (ICANS). In this review, we draw an arc from our current understanding of how systemic and potentially local cytokine release act on the CNS, toward possible preventive and

Совпадение в полном тексте источника
… In patients with multiple sclerosis, single nucleus RNAseq reveals marked expansion of microglia, with transcriptional changes toward a phagocytosing phenotype ( 192 ). … Oral prednisone and methylprednisolone have well established efficacy and safety for neuroinflammatory disorders such as multiple sclerosis and acute demyelinating encephalomyelitis ( 214 , 215 ). …

Воспаление и воспаление болезней, маркеры и посредники: роль КПИ в некоторых воспламенительных заболеваниях

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Совпадение в полном тексте источника
… A heat shock protein family, αβ-crystallin, exerts cell protection under various stress-related conditions developed in the mouse model of multiple sclerosis, spinal cord injury brain ischemia, and Alexander disease. … Delivery-related CRP levels were significantly elevated during delivery among both multiple sclerosis (MS) pregnancy patients and in control pregnant women. CRP levels were higher only during pregnancy in both study groups than during the postpartum period. …

Несбалансированность строения и cholesterol-24-hydroxylase dys Регулирование связано с развитием множественного склероза.

Инвалидность, усугубляющаяся множественным склерозом (MS), связана с нейродегенерацией. Холестерин гомеостазис необходим для нормального функционирования мозга. CYP46A1, что имеет решающее значение для оборота холестерина мозга и уменьшается в некоторых нейродегенеративных заболеваниях, является потенциальной целью нейрозащиты. Мы предположили, что CYP46A1 понижается в мозгах MS и связан с холестерином дисбалансом. Масс-спектрометрический анализ стеролов был проведен на основе совпадающей плазмы и цереброспинной жидкости (CSF) в женской группе MS (n = 32Средний возраст = 33). Инвалидность реги

Совпадение в аннотации оригинала
Disability worsening in multiple sclerosis (MS) is linked to neurodegeneration. Cholesterol homeostasis is essential for normal brain function. CYP46A1, crucial for brain cholesterol turnover and reduced in some neurodegenerative diseases, is a potential neuroprotective target. We hypothesized that CYP46A1 is downregulated in MS brains and linked to choleste…

Proceedings 27th Symposium ESVN‐ECVN

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway.

Transforming growth factor-beta (TGF-β) signaling regulates a wide range of biological processes. TGF-β plays an important role in tumorigenesis and contributes to the hallmarks of cancer, including tumor proliferation, invasion and metastasis, inflammation, angiogenesis, and escape of immune surveillance. There are several pharmacological approaches to block TGF-β signaling, such as monoclonal antibodies, vaccines, antisense oligonucleotides, and small molecule inhibitors. Galunisertib (LY2157299 monohydrate) is an oral small molecule inhibitor of the TGF-β receptor I kinase that specifically

Managing fatigue in patients with primary Sjögren's syndrome: challenges and solutions.

Primary Sjögren's syndrome (pSS) patients identify fatigue as their most important symptom and the one most difficult to cope with, but there are still many challenges and few solutions to manage this debilitating symptom. Promising pharmacological treatments, such as rituximab, have failed in more stringent tests including randomized controlled trials (RCTs) and meta-analysis. While non-pharmacological interventions may be safer, less costly, and address other common comorbidities, to date only aerobic exercise seems to be effective at reducing fatigue in pSS. All interventions, pharmacologic

Совпадение в полном тексте источника
… Application to patients with multiple sclerosis and systemic lupus erythematosus . Arch Neurol . 1989 ; 46 : 1121 – 1123 . 2803071 10.1001/archneur.1989.00520460115022 34. Webster K , Cella D , Yost K . … The sphingosine-1-phosphate receptor: A novel therapeutic target for multiple sclerosis and other autoimmune diseases . Clin Immunol . 2017 ; 175 : 10 – 15 . doi: 10.1016/j.clim.2016.11.008 27890706 PMC5315594 101. Iftikhar I , Bittencourt L , Youngstedt S , et al. …

The Emerging Role of Interleukin-32 in HIV-Associated Cardiovascular Comorbidities: A Mini Review.

With the widespread use of antiretroviral therapy (ART), the life expectancy of people living with HIV (PLWH) has significantly improved. However, the incidence of cardiovascular disease (CVD) in this population has progressively increased. PLWH exhibit a significantly higher risk of cardiovascular diseases compared to the general population. Consequently, CVD has become one of the leading contributors to mortality not related to AIDS. The pathogenesis may involve several factors: HIV-related proteins exacerbating endothelial injury and inflammation; immune activation and chronic inflammation;

Effects of Acetylcholine on Endothelial Function and Nitric Oxide Levels in Patients with Type 2 Diabetes Mellitus: A Randomized Sham-Controlled Study.

BACKGROUND: Peripheral neuropathy is a prevalent neurological disorder with multiple etiologies. Nerve damage frequently occurs due to prolonged high blood sugar levels and diabetes. Peripheral nerve fiber impairment, mediated mainly through dysregulation of Nitric Oxide Synthase (NOS) activity, induces irreversible structural damage. Acetylcholine induces vasodilation by stimulating endothelial nitric oxide (NO) production, which relaxes smooth muscle, and by triggering a nerve axon reflex. This reflex releases neuropeptides like substance P, which further dilate vessels and prompt histamine

Overcoming obstacles to repurposing for neurodegenerative disease.

Repurposing Food and Drug Administration (FDA)-approved drugs for a new indication may offer an accelerated pathway for new treatments to patients but is also fraught with significant commercial, regulatory, and reimbursement challenges. The Alzheimer's Drug Discovery Foundation (ADDF) and the Michael J. Fox Foundation for Parkinson's Research (MJFF) convened an advisory panel in October 2013 to understand stakeholder perspectives related to repurposing FDA-approved drugs for neurodegenerative diseases. Here, we present opportunities on how philanthropy, industry, and government can begin to a

Совпадение в полном тексте источника
… An example of what can happen if IP barriers can be surmounted is the multiple sclerosis (MS) drug, BG-12, marketed as Tecfidera developed by Biogen Idec (Cambridge, MA, USA), also called dimethyl fumerate or DMF. …

Biology and Diseases of Dogs

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Comparison of oral chronic graft-versus-host disease characteristics between patients with malignant and non-malignant hematopoietic disorders.

ObjectivesTo characterize and compare the clinical manifestations of oral chronic graft-versus-host disease (cGVHD) in patients with malignant hematopoietic disorders versus those with non-malignant hematopoietic disorders, and to analyze associated risk factors.Materials and methodsDetailed examinations of the oral cavity were conducted in patients with malignant hematopoietic disorders (n = 52) and non-malignant hematopoietic disorders (n = 56) who developed oral cGVHD following allogeneic hematopoietic stem cell transplantation (allo-HSCT). The severity of oral cGVHD was scored, and logisti

Thalidomide Suppresses Angiogenesis Through the Signal Transducer and Activator of Transcription 3/SP4 Signaling Pathway in the Peritoneal Membrane.

Peritoneal angiogenesis is the key pathophysiological factor that limits peritoneal ultrafiltration during peritoneal dialysis (PD) in uremic patients. Thalidomide has been confirmed to inhibit angiogenesis by inhibiting the secretion of vascular endothelial growth factor (VEGF), but the exact mechanism by which thalidomide inhibits vascular proliferation during PD is still unclear. Here, the objective of the present study was to investigate whether the reduction in VEGF production by human peritoneal mesothelial cells (HPMCs) was controlled by thalidomide. Stimulation of HPMCs with IL-6 in co

Повышенное гликозилирование автоантител во время лечения истощения клеток B.

Для ряда хронических аутоиммунных заболеваний характерна повышенная аутоантибодиозная гликозилация Fab. Остается неясным, связаны ли Fab glycans со состоянием заболевания или развитием, но могут ли они служить его показателем. Многие аутоиммунные заболевания лечатся с помощью методов лечения истощения клеток В, что в первую очередь приводит к сокращению числа автоантител. Возникает вопрос, может ли терапия разрушения клеток B оказать воздействие на гликозилацию Fab. Здесь мы изучили продольное воздействие терапии истощения клеток B на гликозилацию Fab для общего ИгГ и IgG автоантифитов в ревма

Совпадение в аннотации оригинала
Several chronic autoimmune diseases are characterized by elevated autoantibody Fab glycosylation. Whether Fab glycans link to disease state … bodies in rheumatoid arthritis (RA), pemphigus vulgaris (PV), ANCA-associated vasculitis (AAV), and multiple sclerosis (MS). Baseline Fab glycosylation was compared to 6-12 months into therapy by lectin affinity chromatography, determining Fab sialylation as an estimate of Fab glycosylation. We observed a modest decrease in Fab glycosylation of total IgG for RA (med …

The Italian Society of Andrology and Sexual Medicine (SIAMS), along with ten other Italian Scientific Societies, guidelines on the diagnosis and management of erectile dysfunction.

PURPOSE: Erectile dysfunction (ED) is one of the most prevalent male sexual dysfunctions. ED has been in the past mistakenly considered a purely psycho-sexological symptom by patients and doctors. However, an ever-growing body of evidence supporting the role of several organic factors in the pathophysiological mechanisms underlying ED has been recognized. METHODS: The Italian Society of Andrology and Sexual Medicine (SIAMS) commissioned an expert task force involving several other National Societies to provide an updated guideline on the diagnosis and management of ED. Derived recommendations

Совпадение в полном тексте источника
… Sclerosis Epilepsy Peripheral nervous system disorders involving pelvic plexus Urological risk factors Lower Urinary Tract Symptoms Chronic prostatitis/chronic pelvic pain syndrome Induratio Penis Plastica Congenital or acquired penile anatomical abnormalities Toxicological and iatrogenic risk factors … Other central neurological diseases frequently associated with an increased risk of ED are multiple system atrophy [ 94 ], multiple sclerosis [ 95 ] and epilepsy [ 96 ]. …

Lipocalin 2-not only a biomarker: a study of current literature and systematic findings of ongoing clinical trials.

Lipocalin 2 (Lcn2), also known as neutrophil gelatinase-associated lipocalin, is an innate immune protein encoded by the LCN2 gene. In this study, we investigated various roles and functions of Lcn2 characterized in a systems-based format and evaluated its therapeutic potentials and clinical relevance for diagnosis and prognosis. An additional systematic presentation was presented for 70 ongoing clinical trials utilizing Lcn2 in the diagnostic and prognostic setting as a key outcome measure. With trials being conducted through December 2030, Lcn2 will become all the more relevant given its ass

Совпадение в полном тексте источника
… lipocalin; diagnostic test: renal resistive index | NGAL; renal resistive index NCT05290077 | Role of NGAL in Vitiligo | Not yet recruiting | Vitiligo | Diagnostic test: NGAL | Serum neutrophil gelatinase–associated lipocalin in patients with vitiligo NCT04574024 | HFP (High-Fiber Supplement) in MS (Multiple … Sclerosis) | Enrolling by invitation | Multiple sclerosis | Drug: NBT-NM108 (60 g/day); other: NBT-NM108 (0 g/day) | Effect of high-fiber supplement (HFS) on (1) composition of gut microbiota and (2) production of short-chain fatty acids (SCFAs) and Foxp3 regulatory T cells (Tregs); examine fecal Lcn …

Reconciling uncertainty of costs and outcomes with the need for access to orphan medicinal products: a comparative study of managed entry agreements across seven European countries.

BackgroundNational payers across Europe have been increasingly looking into innovative reimbursement approaches - called managed entry agreements (MEAs) - to balance the need to provide rapid access to potentially beneficial orphan medicinal products (OMPs) with the requirements to circumscribe uncertainty, obtain best value for money or to ensure affordability. This study aimed to identify, describe and classify MEAs applied to OMPs by national payers and to analyse their practice in Europe.MethodsTo identify and describe MEAs, national health technology assessments and reimbursement decision

Совпадение в полном тексте источника
… Cost effective provision of disease modifying therapies for people with multiple sclerosis: health service circular 2002/004. London: Department of Health; 2002. Ref Type: Report. … National Institute for Health and Clinical Excellence (NICE) Multiple sclerosis - beta interferon and glatiramer acetate: TA32. London: National Institute for Health and Clinical Excellence (NICE); 2002. Ref Type: Report. National Institute for Health and Clinical Excellence (NICE. …

Включаю T-камеры для очистки.

Те, кто занимается клетками, представляют собой преобразующий подход к иммунотерапии рака, стимулирующий использование двухуровневых и многообразных антителных конструкций для перенаправления китотоксичности Т-клеток на злокачественные клетки. Эти молекулы соединяют клетки Т и клетки опухоли, одновременно связывая CD3 с Т клетками и связанными с опухолью антигенами на раковые клетки, что позволяет точно определить иммунную направленность даже в иммунологических "холодных" опухолях. Последние достижения включают в себя условное использование Т-клеток, активированное микроэкологическими протезам

Совпадение в аннотации оригинала
T-cell engagers represent a transformative approach to cancer immunotherapy leveraging bispecific and multispecific antibody constructs to r … ise for restoring immune tolerance in such conditions as HLA-B*27-associated autoimmunity subtypes, multiple sclerosis, rheumatoid arthritis, and type 1 diabetes mellitus. Engineering strategies that incorporate inhibitory receptors or tissue-specific antigens may further refine T-cell engagers' therapeutic potential in autoimmunity, by minimizing systemic immunosup …

Изучение антивоспламенительных эффектов после экстраполяции в модели мыши R6/2 болезни Хантингтона.

Болезнь Хантингтона - это прогрессивное, неизлечимое нейродегенеративное расстройство, вызванное мутацией в гене Хантингтин. Помимо нейродегенерации, изменённая иммунная активация связана с развитием болезни. Поскольку воспаление центральной нервной системы и дисфункция иммунных клеток признаются в качестве движущей силы, иммуномодуляция может представлять собой дополнительную терапевтическую стратегию. Известно, что короткоцепные жирные кислоты оказывают иммуномодулятивное воздействие на нервно-воспалительные заболевания, такие, как множественный склероз. В этом исследовании R6/2 мышей ежедне

Совпадение в аннотации оригинала
Huntington's disease is a progressive, untreatable neurodegenerative disorder caused by a mutation in the Huntingtin gene. Next to neurodege … hain fatty acids were known to have immunomodulatory effects in neuroinflammatory diseases, such as multiple sclerosis. In this study, R6/2 mice were treated daily with 150 mM propionate. Survival range, body weight, and motor abilities were monitored. In striatal and cortical samples, neuronal survival was analyzed by immunofluorescence staining of NeuN-positive ce …

Ось MLKLOPTN регулирует вызванные герпесвирусом неврологические сиквелы.

КОЛИЧЕСТВО: герпес просторексовый вирус-1 (HSV-1) носит пожизненный характер и связан с неврологическими заболеваниями, такими, как множественный склероз (MS), однако основные механизмы в хосте остаются недостаточно понятными. МЕТОДЫ И РЕЗУЛЬТАТЫ: В настоящем исследовании изучается новая молекулярная динамика после заражения HSV-1, выявляется ключевая роль смешанного киназа-домена (MLKL). Помимо известной функции в некроптозе, было установлено, что MLKL контролирует перенос HSV-1 в ядро, жестко регулируемый Оптинёрином (Optineurin). Мы продемонстрировали существенное нормативное взаимодействие

Совпадение в аннотации оригинала
BACKGROUND: Herpes simplex virus-1 (HSV-1) infections are lifelong and linked to neurological diseases such as multiple sclerosis (MS), yet the underlying mechanisms in the host remain poorly understood. METHODS AND RESULTS: This study investigates new molecular dynamics following HSV-1 infection, uncovering the pivotal role of the mixed lineage kinase doma…